HD LABS RETRATRUDE 64MG SELF MIX

HD Labs Retatrutide Self-Mix 64mg is marketed as a powdered retatrutide vial. Retatrutide is an investigational compound that targets three hormone receptors: GIP, GLP-1, and glucagon. These pathways are involved in appetite regulation, blood glucose control, and energy metabolism.

Clinical trials are evaluating retatrutide’s potential for weight management and metabolic conditions. Findings from these trials do not establish the quality, safety, or effectiveness of the HD Labs self-mix product.

Potential Benefits Under Investigation

Reduction in body weight.

Improvements in blood glucose regulation.

Effects on appetite and energy metabolism.

Long-term benefits and safety remain under investigation. Retatrutide should not be described as a proven treatment for reversing insulin resistance.

Possible Side Effects

Reported adverse effects in clinical trials include nausea, vomiting, diarrhoea, constipation, and injection-site reactions.